“…Meanwhile, nitric oxide may be a potential mediator of hepatic inflammation and fibrogenesis in AIH. The serum nitric oxide metabolites like inducible nitric oxide synthase (iNOS) and nitric oxide activity can reflect oxidant stress in the liver and detect the inflammation and disease progression (Lloyd, Phillips, Cooper, & Dunbar, 2008;Yang, Zhang, Han, Jin, & Yang, 2017). In addition, various surface markers and cytokines are expressed and secreted, respectively, by the classical activation (M1) and the alternative activation phenotypes (M2), both of which have variable impacts in the context of immunoregulation (Ivashkiv, 2013;Ka, Daumas, Textoris, & Mege, 2014;Ying, Cheruku, Bazer, Safe, & Zhou, 2013).…”